Advertisement
Advertisement
-
TOPIC

Biomedicine: Policy

Related Topics:
Biomedicine: Policy
Learn about China’s biomedical breakthroughs, from cutting-edge pharmaceuticals to life-saving research, driving global health innovation.
China challenges US in new drugs after industry transformation
China’s private sector

Biomedicine | China challenges US in new drugs after industry transformation

Drug makers in China are performing cutting-edge research and licensing products to global giants after a 10-year government push supercharged the industry.

Made in China 2025

Chinese biotechs strike a record US$136 billion in out-licensing deals in 2025

Made in China 2025

China’s new drug insurance: lifeline for patients or squeeze on big firms?

China economy

Opinion | How China engineered the rapid rise of its drug innovation industry

A market once dominated by generics is now an AI-powered pharmaceutical hub drawing billion-dollar investments from the likes of Pfizer and GSK.

videocam
A worker checks the position of a feeding tray in a pharmaceutical manufacturing facility at the Hengrui Biomedical Industrial Park in Lianyungang in Jiangsu province, on December 13, 2021. Photo: Getty Images
Hong Kong healthcare and hospitals

Editorial | Hospital fee reform must balance social fairness with budgetary needs

While standard X-ray services at public hospitals will remain free, the pricing overhaul must be watched closely to avoid unintended harm.

Biomedicine: Industry Trends

China’s clinical trial capacity matches US, attracts more global pharma firms

Growth of innovative clinical trials suggests that Chinese biotech firms’ pipeline of novel drug candidates is expanding, analysts say.

Advertisement
Advertisement
Advertisement
New medical drugs

6 of the best: the billion-dollar biotechs putting China on the map

China’s biotech renaissance is gathering pace as home-grown innovators strike billion-dollar licensing deals with global giants.

Illustration: Henry Wong
China’s private sector

‘Quantity to quality’: what China’s next 5-year plan means for foreign investors

Beijing has pledged to open up even more to foreign investment. But some officials are becoming more selective about the projects they want.

videocam
Biomedicine: Industry Trends

China’s drug developers stretch to become a global force

Although a start-up’s recent triumph is seen as a ‘DeepSeek moment’, domestic players still trail world-beating pharma firms, experts say.

10
Baidu

Baidu-backed drug discovery start-up Biomap challenges Google’s AlphaFold

Biomap expects to double its revenue this year, co-founder and CEO Wei Liu says.

From left to right: HKIC CEO Clara Chan Ka-chai, Financial Secretary Paul Chan Mo-po and Biomap CEO Wei Liu at a signing ceremony in June. Photo: Handout
US-China tech war

Chinese 3D biomolecule imaging start-up aims for IPO in 2027

Shuimu BioSciences is the first Chinese company to develop its own cryo-electron microscopy machine, a vital tool in drug discovery.

Allen Guo Chunlong, co-founder and CEO Shuimu BioSciences. Photo: Handout
China manufacturing

China closes biotech gap with US as new drugs, pipelines top 30% of global total

Beijing has ramped up support for the bioeconomy with a five-year plan aimed at making the country a global leader by 2035.

Biomedicine: Companies

China’s biomedicine sector takes off

China’s novel drug industry is experiencing a meteoric rise, fuelled by the increased development of new medicines and the prospect of many patents expiring.

Hong Kong economy

Opinion | How Hong Kong can lead in patient-focused ethical AI healthcare

AI can improve disease detection, surgery accuracy and data management but healthcare professionals can do a lot of good that AI cannot.

videocam
Illustration: Stephen Case
Biomedicine: Companies

Hong Kong firms eye Chinese medicine opportunities on the mainland: HKTDC

Hong Kong Trade Development Council says streamlined procedures opened a more convenient channel for companies to expand into the mainland.

Test samples in a lab at the Macau University of Science and Technology. Photo: Edmond So
China manufacturing

China approving innovative drugs at record pace, shifting momentum from West

‘If we’re not careful, every drug could be made in China,’ warned former head of US Food and Drug Administration in May.

videocam
8
Biomedicine: Companies

China’s plan to boost drug coverage no ‘magic wand’: analysts

Drug companies will be eager to have their products approved, but insurers will struggle to offer attractive coverage, analysts say.

Advertisement
Advertisement
Advertisement
Biomedicine: Companies

CUHK start-ups eye silver economy’s need for ‘wearable robotics’

Start-ups seek to enter the growing markets for elderly care and rehabilitation by selling their ‘wearable robotics’ technologies.

RT HealthTech co-founder Raymond Tong Kai-yu. Photo: Jonathan Wong
China's economic recovery

Explainer | Why is Xi turning to the ocean for China’s growth – and who benefits?

Beijing eyes ocean-driven growth, as Chinese leader pledges more support for offshore sectors like wind power, shipping and marine biotech.

Artificial intelligence

XPrize founder Diamandis projects hope for AI, biotech amid US-China tech war

The entrepreneur says biotech should be less contentious than AI, as a breakthrough in Beijing is just as usable in Boston.

videocam
Biomedicine: Companies

Big Chinese pharma can beat Trump’s policies with cost efficiencies: analysts

Trump seeks to slash domestic drug prices, bring back pharmaceutical manufacturing to the US and slap tariffs on imports.

videocam
A humanoid robot is shown delivering drugs at a mock pharmacy in Beijing in April 2025. Photo: EPA-EFE
Biomedicine: Companies

US report highlights China’s biotech rise, urges action to boost local industry

China is ‘quickly ascending to biotechnology dominance’ and the US must ‘take swift action in the next three years’, the report says.

4
The logo of Wuxi AppTec is displayed alongside the company’s website, in this illustration picture taken February 5, 2024. Photo: Reuters
Biomedicine: Companies

Chinese biotech firms cash in on promising drug discoveries via licensing

China has 4,804 new drug candidates under development, second only to the US at 5,268, according to data provider PharmCube.

videocam
Artificial intelligence

China’s tech push: Shanghai aims to be global medical AI hub by 2027

Despite US export curbs on advanced chips, China’s financial powerhouse is betting big on medical AI.

Biomedicine: Companies

Hong Kong residents reticent to get latest Covid-19 jab, Moderna survey finds

About 52 per cent of Hong Kong respondents said they were willing to get the updated vaccine, compared with 58 per cent in Singapore.

Moderna’s survey results indicate a “growing complacency” even as coronavirus variants continue to evolve. Photo: Shutterstock
Biomedicine: Companies

China welcomes new US$1 billion Sanofi project in Beijing

Sanofi’s latest capital outlay in China will cover the development of a new insulin plant in the nation’s capital.

Sanofi said the new plant in Beijing will be its fourth such facility on the mainland. Photo: Shutterstock
Health & Fitness

China expands health insurance coverage with 91 new drugs, innovative treatments

The health authority shows its support for novel drugs, while driving tough bargains with pharmaceutical firms on prices.

videocam
Biomedicine: Companies

Chinese biotech firms brace for Trump tariffs, US funding bill

Efforts to expand sales of high-value products in China and non-US markets would cushion the blow, analysts say.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement